Category: New Treatment
-
HP Roadshow heads north
Posted on:
Northern Sydney Local Health District hosted the latest stop on Sydney Health Partners’ 2025 roadshow, Translation in Action. More than 70 researchers and clinicians gathered at the Kolling Institute to hear presentations by colleagues involved in translational research projects, and to see how Sydney Health Partners is assisting research translation. The Kolling’s Academic Director Professor
-
New study tests how stress and big meals can trigger a heart attack
Posted on:
A heavy Christmas lunch, an argument or even smoke from a bushfire may seem harmless, but for people at risk of heart disease, they could be deadly. A new study is investigating how emotional stress, pollution, chest infections, and large meals can trigger heart attacks in vulnerable people, and importantly, how to manage those triggers
-
September 2025 Kolling NEWS
Posted on:
Our latest Kolling Institute newsletter is out detailing the very latest updates from our expert team of researchers, including some promising progress with our bowel cancer investigators. There’s an opportunity to join a clinical trial to minimise the impact of osteoarthritis, a new approach to reduce spinal cord injury related pain and an international award recognising 40
-
Kolling Institute Year in Review
Posted on:
The Kolling Institute Year in Review profiles our impressive and unique teams, and the impact of their crucial research. Our investigators are driving world-leading research into some of the most significant health challenges, from heart and kidney disease, chronic pain and cancer, to musculoskeletal, neurological and age-related conditions. With a large share of our researchers named amongst
-
Researchers work to reduce debilitating spinal cord injury pain
Posted on:
When we think of the impact of a spinal cord injury, we tend to focus on the significant limitations with the loss of mobility, but for a large share of people living with this injury, it’s actually the chronic pain which is one of the most challenging issues to manage long-term. Neuropathic pain affects about
-
Researchers helping those with osteoarthritis weave more exercise into their day
Posted on:
Our researchers at the Kolling Institute are leading a national clinical trial to support people with hip or knee osteoarthritis become more active. Study co-lead Dr Vicky Duong said we know that staying active is an important part of managing osteoarthritis symptoms, and yet 90 per cent of people with the condition are not meeting
Category:
-
Combining medication and exercise could greatly reduce osteoporosis risk
Posted on:
Researchers from the Kolling Institute and Royal North Shore Hospital are inviting women aged 50-80 to join a study to assess the effectiveness of combining exercise with medication for better bone and muscle health in postmenopausal women. Endocrinologist and researcher Dr Shejil Kumar said we know that exercise has benefits for bone and muscle health,
-
International honour for Kolling researcher after 40-year service to spinal cord injury care
Posted on:
A career dedicated to improving the physiotherapy management of people with spinal cord injury has been recognised with the highest honour by the International Spinal Cord Society. Leading physiotherapist and researcher Professor Lisa Harvey was presented with the gold medal in front of the world’s best spinal cord injury clinicians and researchers in Belgium. Professor
-
Improving cancer detection in young people with neurofibromatosis type 1
Posted on:
Researchers from Royal North Shore Hospital and the Kolling Institute will lead Australia’s first study of whole-body screening for young people with neurofibromatosis type 1. Led by Dr Sue-Faye Siow from the department of clinical genetics, the study was awarded a grant through the RNSH Campus Research Grants Scheme, and an additional $30,000 in support
Category:
-
Pioneering study to improve sleep and reduce musculoskeletal pain
Posted on:
An innovative study, led by a team of researchers from the Kolling Institute, has the potential to change the way osteoarthritis and low back pain are managed. More than $4.7 million has been awarded to the project through the Medical Research Future Fund’s program for early to mid-career researchers. Study lead Associate Professor Michelle Hall
Category: